Switch to
More onapp

How to use scorecard? Learn more

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹928 cr, stock is ranked 1,397
High RiskStock is 4.35x as volatile as Nifty
332.150.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹928 cr, stock is ranked 1,397
High RiskStock is 4.35x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
41.32
PB RatioPB Ratio
5.84
Dividend YieldDiv. Yield
1.41%
Sector PESector PE
125.27
Sector PBSector PB
7.50
Sector Div YldSctr Div Yld
0.60%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jagsonpal Pharmaceuticals Limited is engaged in pharmaceutical business. It specializes in developing and manufacturing bulk drugs and pharmaceutical formulations.

Financial TrendFinancial statements 

2021202220232024192.34221.01242.44217.9817.0518.8526.7122.46
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting-XBRL 
Announced OnMay 21, 2024

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on 20-May-2024 for Dividend | Download

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on 20-May-2024 for Dividend | Download

Related Party Transactions 
Announced OnMay 20, 2024

Jagsonpal Pharmaceuticals Limited has informed the Exchange about related Party Transactions | Download

Jagsonpal Pharmaceuticals Limited has informed the Exchange about related Party Transactions | Download

Cash Dividend 
Ex. DateAug 21, 2023

Final • Div/Share: ₹ 5

See all events